“Too many women’s scripts never even get a read,” co-founder Jan Kimbrough says. “We exist to change that." By Kimberly Nordyke Managing Editor, Digital The Women’s List, a nonprofit organization ...

It’s been over a year, and fans are still grieving the monumental loss of David Lynch. But there’s a spark of hope that we may get to dive into one of the legendary creator’s most mysterious ...

The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices. By Rebecca Robbins and Reed Abelson The reporters have ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

David Lynch’s family will release scripts for an unrealised project by the late director called Unrecorded Night, according to a new post by the late director’s daughter. Lynch had pitched a new ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

A developer-targeting campaign leveraged malicious Next.js repositories to trigger a covert RCE-to-C2 chain through standard ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy benefit managers, requiring sweeping changes aimed at lowering insulin costs ...

It’s now been over a year since the great David Lynch departed this Earth, and with his passing he left a number of unrealized projects. The major one was Unrecorded Night, a series set to be produced ...

Express Scripts to change practices tied to high costs FTC to enforce 10-year settlement Deal requires company to work with local pharmacies Sign up here. "Our ...

Attackers used “technical assessment” projects with repeatable naming conventions to blend in cloning and build workflows, ...

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...